Oral exposure to high concentrations of polystyrene microplastics alters the intestinal environment and metabolic

Yuka Hasegawa1, Takuro Okamura1, Yuriko Ono1

  • 1Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Frontiers in Immunology
|November 27, 2024
PubMed
Abstract

Insights

High concentrations of microplastics (MPs) cause dyslipidemia and fatty liver disease even without leaky gut syndrome. MPs disrupt gut microbiota and induce intestinal inflammation, underscoring the need to reduce environmental exposure.

Area of Science:

  • Environmental Health
  • Toxicology
  • Gastroenterology

Background:

  • Oral exposure to microplastics (MPs) is a growing global health concern.
  • Previous research linked MPs to glucose intolerance and non-alcoholic fatty liver disease (NAFLD) under specific dietary conditions.
  • The impact of high MP concentrations on lipid metabolism and the intestinal tract under normal diets requires further investigation.

Purpose of the Study:

  • To evaluate the effects of high concentrations of MPs on lipid metabolism in mice on a normal diet.
  • To assess MP-induced changes in the intestinal tract, including permeability, gut microbiota, and inflammation.
  • To determine if MPs cause NAFLD and dyslipidemia independent of leaky gut syndrome.

Main Methods:

  • C57BL6/J mice were fed a normal diet with or without polystyrene MPs (PS-MPs) at high concentrations (1000 µg/L or 5000 µg/L) for six weeks.
  • Intestinal permeability, gut microbiota composition, and serum, fecal, and liver metabolite levels were analyzed.
  • Changes in immune cell populations and gene expression related to nutrient transport were also assessed.

Main Results:

  • High MP concentrations increased serum lipid levels and exacerbated fatty liver function, despite no increase in intestinal permeability.
  • MP exposure altered gut microbiota, induced intestinal inflammation mediated by natural killer cells, and modulated nutrient transport gene expression.
  • The severity of intestinal disturbances correlated with MP dose.

Conclusions:

  • High-dose oral microplastic exposure can induce dyslipidemia and NAFLD even in the absence of leaky gut syndrome.
  • Microplastics trigger intestinal inflammation and alter gut microbiota, impacting nutrient metabolism.
  • Reducing environmental microplastic exposure is crucial to mitigate adverse health effects.